X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1630) 1630
life sciences & biomedicine (1591) 1591
humans (1426) 1426
male (1368) 1368
animals (882) 882
indans - therapeutic use (867) 867
female (847) 847
indans - pharmacology (819) 819
indans - administration & dosage (811) 811
aged (660) 660
pharmacology & pharmacy (595) 595
neurosciences & neurology (580) 580
donepezil (579) 579
piperidines - therapeutic use (531) 531
alzheimer disease - drug therapy (500) 500
middle aged (489) 489
rats (483) 483
indans - adverse effects (426) 426
alzheimer's disease (423) 423
treatment outcome (422) 422
neurosciences (413) 413
cholinesterase inhibitors - therapeutic use (391) 391
dose-response relationship, drug (389) 389
piperidines - administration & dosage (377) 377
piperidines - pharmacology (339) 339
clinical neurology (308) 308
double-blind method (289) 289
psychiatry (287) 287
adult (285) 285
aged, 80 and over (283) 283
cholinesterase inhibitors - administration & dosage (268) 268
cholinesterase inhibitors - pharmacology (256) 256
mice (243) 243
drug therapy (240) 240
piperidines - adverse effects (230) 230
time factors (229) 229
pulmonary disease, chronic obstructive - drug therapy (206) 206
rats, sprague-dawley (205) 205
indans - pharmacokinetics (204) 204
quinolones - administration & dosage (182) 182
cholinesterase inhibitors - adverse effects (175) 175
nootropic agents - therapeutic use (175) 175
drug therapy, combination (174) 174
analysis (165) 165
administration, oral (161) 161
severity of illness index (161) 161
drug administration schedule (160) 160
geriatrics & gerontology (158) 158
disease models, animal (154) 154
rats, wistar (153) 153
dementia (150) 150
alzheimers disease (142) 142
cholinesterase inhibitors (142) 142
rivastigmine (142) 142
bronchodilator agents - administration & dosage (133) 133
parkinson disease - drug therapy (133) 133
neurology (132) 132
respiratory system (132) 132
neuropsychological tests (130) 130
parkinson's disease (130) 130
research (130) 130
abridged index medicus (127) 127
indacaterol (126) 126
brain - drug effects (123) 123
care and treatment (119) 119
cognition - drug effects (118) 118
rasagiline (113) 113
nootropic agents - administration & dosage (112) 112
dosage and administration (108) 108
medicine & public health (108) 108
quinolones - therapeutic use (106) 106
lung diseases, obstructive (104) 104
pulmonary disease, chronic obstructive - physiopathology (104) 104
indans - chemistry (103) 103
clinical trials (102) 102
pharmacology/toxicology (102) 102
piperidines - pharmacokinetics (102) 102
cognition disorders - drug therapy (101) 101
administration, inhalation (97) 97
cognition (97) 97
alzheimer disease - psychology (96) 96
clinical trials as topic (93) 93
behavior, animal - drug effects (92) 92
randomized controlled trials as topic (92) 92
maze learning - drug effects (91) 91
quinolones - adverse effects (90) 90
drug interactions (89) 89
biochemistry & molecular biology (88) 88
cardiovascular system & cardiology (88) 88
galantamine - therapeutic use (88) 88
adrenergic beta-2 receptor agonists - administration & dosage (86) 86
memory (85) 85
brain - metabolism (84) 84
internal medicine (83) 83
chronic obstructive pulmonary disease (82) 82
nootropic agents - adverse effects (82) 82
acetylcholine (81) 81
blood pressure - drug effects (81) 81
dementia - drug therapy (81) 81
rodents (81) 81
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2062) 2062
Japanese (45) 45
German (18) 18
French (14) 14
Spanish (9) 9
Chinese (5) 5
Russian (5) 5
Portuguese (3) 3
Danish (2) 2
Hungarian (2) 2
Norwegian (2) 2
Polish (2) 2
Finnish (1) 1
Italian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet respiratory medicine, ISSN 2213-2600, 03/2013, Volume 1, Issue 1, pp. 51 - 60
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2018, Volume 391, Issue 10125, pp. 1076 - 1084
Journal Article
Expert Review of Respiratory Medicine, ISSN 1747-6348, 06/2014, Volume 8, Issue 3, pp. 357 - 379
Journal Article
The lancet respiratory medicine, ISSN 2213-2600, 05/2013, Volume 1, Issue 3, pp. 199 - 209
Journal Article
Journal Article
International journal of chronic obstructive pulmonary disease, ISSN 1176-9106, 05/2017, Volume 12, pp. 1325 - 1337
Background: Endpoints that evaluate deterioration rather than improvement of disease may have clinical utility in COPD. In this analysis, we compared the... 
IND/GLY | Deterioration | COPD | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Indans - adverse effects | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Fluticasone-Salmeterol Drug Combination - adverse effects | Forced Expiratory Volume | Clinical Trials, Phase III as Topic | Quinolones - adverse effects | Tiotropium Bromide - administration & dosage | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Endpoint Determination | Female | Surveys and Questionnaires | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Glucocorticoids - adverse effects | Glycopyrrolate - adverse effects | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Tiotropium Bromide - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Lung - physiopathology | Disease Progression | Fluticasone-Salmeterol Drug Combination - administration & dosage | Randomized Controlled Trials as Topic | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Tiotropium | Lung diseases, Obstructive | Indacaterol | Dosage and administration | Glycopyrrolate | Research | Drug therapy | Index Medicus | deterioration
Journal Article
International journal of chronic obstructive pulmonary disease, ISSN 1178-2005, 02/2014, Volume 9, pp. 215 - 228
Background: Addition of a second bronchodilator from a different pharmacological class may benefit patients with moderate-to-severe chronic obstructive... 
Bronchodilation | Indacaterol | Inhalation therapy | Breezhaler | Glycopyrronium | COPD | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Indans - adverse effects | Bronchodilator Agents - administration & dosage | Area Under Curve | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Forced Expiratory Volume | Quinolones - adverse effects | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Indans - administration & dosage | Inspiratory Capacity | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Glycopyrrolate - adverse effects | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Double-Blind Method | Drug Administration Schedule | Europe | Administration, Inhalation | Treatment Outcome | Lung - physiopathology | Muscarinic Antagonists - administration & dosage | Vital Capacity | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Dosage and administration | Glycopyrrolate | Drug therapy, Combination | Drug therapy | Comparative analysis | Index Medicus
Journal Article
Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 2017, Volume 45, pp. 19 - 33
Abstract In this review, we summarize the rationale for combining long-acting bronchodilators in the management of chronic obstructive pulmonary disease... 
Medical Education | Pulmonary/Respiratory | Human | QVA149 | Indacaterol | Dual bronchodilation | Glycopyrronium | COPD | Pharmacology & Pharmacy | Respiratory System | Life Sciences & Biomedicine | Science & Technology | Indans - adverse effects | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Muscarinic Antagonists - adverse effects | Pulmonary Disease, Chronic Obstructive - physiopathology | Quinolones - pharmacology | Quinolones - adverse effects | Adrenergic beta-2 Receptor Agonists - adverse effects | Muscarinic Antagonists - pharmacology | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Glucocorticoids - adverse effects | Glycopyrrolate - adverse effects | Severity of Illness Index | Administration, Inhalation | Bronchodilator Agents - pharmacology | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Animals | Glycopyrrolate - administration & dosage | Adrenergic beta-2 Receptor Agonists - administration & dosage | Glycopyrrolate - pharmacology | Drug Combinations | Indans - pharmacology | Pulmonary Disease, Chronic Obstructive - drug therapy | Sleep disorders | Medical colleges | Pneumonia | Lung diseases, Obstructive | Sleep | Bacterial pneumonia | Analysis | Respiratory agents | Drug therapy, Combination | Index Medicus
Journal Article
Journal Article